XETRA : APPH.DE

Apontis Pharma AG

$11 EUR

$0 (0.0%)

Volume
6.86K
Average Volume
1.21K
Market Capitalization
$91.63M
P/E Ratio
121.55
Dividend Yield
0.00%
Price Target
Year High
$12.35
Year Low
$9.70
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.93
Company Overview

XETRA

Sascha Glanemann

Drug Manufacturers - Specialty & Generic

Healthcare

APPH.DE

137

DE

EUR

https://apontis-pharma.de

49 2173 8955 4949

N/A

N/A

Liquidity Metrics

0.00

4.93

3.78

3.25

0.00

Sales & Valuation

$48.47M

1.89

2.95

-17.48

-0.63

Profitability

$0.0905

$753.57K

1.55%

2.38%

2.46%

1.70%

P/E Metrics

121.55

1.47

1.47

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

6.08

2/9

$17.93M

$43.99M

$12.37M

-$7.93M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Sascha Glanemann Chief Executive Officer & Member of Management Board
Thomas Milz Chief Product Officer & Deputy Chairman of Management Board
Thomas Zimmermann Chief Financial Officer & Member of Management Board
Poll Results

No votes yet today — be the first to share your view!

About Apontis Pharma AG (XETRA:APPH.DE) Stock

Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany. ...

Frequently Asked Questions

What is the current Apontis Pharma AG (APPH.DE) stock price?

Apontis Pharma AG(XETRA:APPH.DE) stock price is $11 in the last trading session. During the trading session, APPH.DE stock reached the peak price of $12.35 while $9.7 was the lowest point it dropped to. The percentage change in APPH.DE stock occurred in the recent session was 0.0% while the dollar amount for the price change in APPH.DE stock was $0.

APPH.DE's industry and sector of operation?

The XETRA listed APPH.DE is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of APPH.DE?

Sascha Glanemann | Chief Executive Officer & Member of Management Board
Thomas Milz | Chief Product Officer & Deputy Chairman of Management Board
Thomas Zimmermann | Chief Financial Officer & Member of Management Board
|
|

How many employees does APPH.DE have?

Number of APPH.DE employees currently stands at 137. APPH.DE operates from Alfred-Nobel-Str. 10, Monheim am Rhein, None 40789, DE.

Link for APPH.DE official website?

Official Website of APPH.DE is: https://apontis-pharma.de

How do I contact APPH.DE?

APPH.DE could be contacted at phone #49 2173 8955 4949 and can also be accessed through its website. APPH.DE operates from Alfred-Nobel-Str. 10, Monheim am Rhein, None 40789, DE.

How many shares of APPH.DE are traded daily?

The average number of APPH.DE shares traded daily for last 3 months was 1.21K.

What is the market cap of APPH.DE currently?

The market value of APPH.DE currently stands at $91.63M with its latest stock price at $11